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Abstract. The clinical picture of acetate intolerance strictly
mimics the nitric oxide (NO) effect, including smooth muscle
relaxation and extreme vasodilation. Because acetate induces
production of cAMP, which is a powerful stimulus of NO
synthase (NOS), we evaluated the effect of different dialysate
solutions with and without acetate on NOS activity in endo-
thelial cells (EC). NOS activity of EC, evaluated as H3-citrul-
line produced from H3-arginine, was modulated by the dialy-
sate composition (e.g. , 38 mmolIL acetate produced an
increase of 3.2 ± 0.39-fold compared with basal values (P <
0.0005), and the small amount of acetate (4 mmol/L) in 35
mmol/L bicarbonate solution increased the NOS activity by
2 ± 0.49-fold (P < 0.05). Conversely, the acetate-free solution
produced no effect on NOS activity. The mRNA encoding for
inducible NOS was highly expressed in EC incubated with
acetate buffer and also with acetate in bicarbonate dialysis
buffer. The EC proliferative index was depressed by acetate
(P < 0.0005), and tumor necrosis factor synthesis was in-
creased (P < 0.0005) compared with acetate-free buffer. This
study suggests that dialytic “acetate intolerance” can be in-
duced by the activation, through cAMP and tumor necrosis
factor release, of NOS. The small amount of acetate in bicar-
bonate dialysate, although capable of inducing in vitro NOS
activation, is likely to be rapidly metabolized, whereas the
large amounts of this anion in acetate fluids overwhelm me-
tabolism by the liver. Acetate-free dialysate is the only solution
that provides an acceptable level of biocompatibility both in
vivo and in vitro. (J Am Soc Nephrol 8: 1431-1436, 1997)
Several studies have shown the beneficial effects of bicarbon-
ate instead of acetate-containing dialysates in reducing the
morbidity associated with dialysis ( 1 ). The benefits include a
lower incidence of arterial hypotension (1-5), improved left
ventricular function (2), and decreased incidence of nausea,
vomiting, and headache (1). These symptoms are the hallmarks
of so-called “acetate intolerance. “ Acetate buffer as a dialysis
fluid induces hemodynamic instability through peripheral va-
sodilation and depression of myocardial contractility (2,5). The
mechanisms by which acetate induces these effects are still not
understood.
It has been proposed that acetate induces vasodilation by
deranging AMP metabolism. Acetate infusion (6) produces an
increase in intracellular levels of AMP as a result of conjuga-
tion of acetate with coenzyme A (CoA) to form acetyl-CoA.
This reaction consumes ATP with production of adenosine and
AMP, which can be transformed in cAMP. In fact, ATP, AMP,
and ADP are interconvertible through adenylate kinase. ATP is
the substrate of adenylate cyclase, an integral membrane pro-
tein, with final production of cAMP.
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Indeed, during acetate-buffered hemodiabysis, platelets be-
come depleted of ATP (7). Most of the adenine nucleotides can
act as vasodilators in preconstricted vessel strips, possibly by
virtue of their effect on purinergic receptors (8), which also
have recently been found on endothelial cells (EC). AMP, but
not adenosine, in high concentrations relaxes the vasopressin-
constricted rat tail artery (9). Studies on healthy volunteers
showed that elevation in blood acetate from the physiological
level of 0. 1 to 1 raM resulted in increased heart rate and
decreased diastolic BP (10). Moreover, acetate per se can
modulate some cellular activities, including interleukin (IL)- 1
synthesis ( 1 1 ). However, the exact mechanism of vasorelax-
ation induced by acetate metabolism is not yet defined.
cAMP and cytokines (12,13) are powerful stimuli of nitric
oxide (NO) synthase (NOS) activity, an NADPH-dependent
family of enzymes. NOS transforms L-arginine (L-Arg) to
L-citrubline and NO with a I : 1 stoichiometry ( 14,15). NO is a
powerful mediator. Smooth muscle relaxation is one of the
most well-known activities induced by NO, and this effect is
mediated by a dose-dependent increase in the levels of cyclic
guanosine monophosphate in smooth muscle ( 16, 1 7) conse-
quent to the activation of soluble guanylate cyclase.
Because some effects of NO overlap with those induced by
acetate, and acetate induces production of cAMP and cyto-
kines, which in turn can give rise to NO synthesis, we focused
on whether the acetate contained in dialysis fluids can influ-
ence NO production by EC. We also evaluated the influence of
acetate on tumor necrosis factor (TNF)-a production and pro-
liferative activity of EC.
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Materials and Methods
Experimental Design
Murine EC were incubated for 6 h with different dialysis fluids
with or without acetate: (1) acetate, 38 mmolIL; (2) bicarbonate, 35
mmol/L, acetate 4 mmol/L; (3) acetate-free buffer (AFB). All of these
conditions were studied with or without lipopolysaccharide (LPS) (10
p.g/ml). Cell culture supernatants, cell enzymatic and proliferative
activity, and specific mRNA synthesis were then evaluated.
Cells
To avoid using different human cell donors, sequential passages,
and protracted manipulations, the murine endothelioma cell line T
End. 1 ( 18) was selected for the experiments. T End. I cells were
maintained in Dulbecco’s modified Eagle’s medium (DMEM)
(Sigma. St Louis, MO) containing 10% fetal calf serum (Sigma),
penicillin. streptomycin, and amphotericin (Sigma). Experiments were
performed at the 98th through 166th passage. The mouse EC line
End. 1 , derived from a thymic hemangioma expressing the polyoma
middle T antigen (19). retains functional properties of normal EC.
These cells proliferate at confluence without overgrowth, take up
acetylated LDL, and express CD3 I . VCAM- 1 , E-selectin, and P-
selectin, respond to IL-lp, TNF-a, and specific EC growth factors,
and produce IL-6 and chemokines (19,20).
Culture Conditions
EC were cultured at 37#{176}Cin an environment of 95% air and 5%
CO2 and in DMEM-supplemented media. Cells were then incubated
for 6 h with different dialysis fluids with or without acetate: (1) 38
mmob/L acetate, 140 mmol/L Na, 2 mmollL K, 1.75 mmollL Ca2,
0.75 mmob/L Mg2, 1 10.0 mmollL Cb, and 5.55 mmol/L glucose;
(2) 35 mmol/L bicarbonate, 4 mmol/L acetate, 143 mmol/L Na, 2
mmol/L K, 1.75 mmolIL Ca2, 0.75 mmolIL Mg2, 110.5 mmol/L
Cr, and 5.55 mmol/L glucose; (3) AFB: 139 mmoblL Nat, 2 mmol/L
K , 2 mmol/L Ca2 , 0.37 mmolIL Mg2, 145.74 mmollL Cl, and
5.5 mmol/L glucose. At the end of incubation, culture supernatants
were collected for TNF-a measurements. After three washes with
Hanks’ Ca+ +, Mg+ +-free solution (Sigma), EC were trypsinized
and suspended in reaction buffer for NOS activity (see below) or in
sterile phosphate-buffered saline, 0.15 M (pH 7.3), for RNA extrac-
tion. The cells were snap-frozen and stored at -80#{176}Cuntil use.
NO Measurement
EC were frozen in 1 ml of reaction buffer containing (in mM) 20
Hepes, 0.5 ethylene diamine tetra-acetic acid, and 1 dithiothreitol, pH
7.2, sonicated on ice with three 10-s bursts. In each test tube, the
following reagents were added to 100 l of sonicate at the final
concentrations: 2 mM NADPH, 1.5 mM CaCI.,, 1 to 100 j.M L-Arg,
2.5 j.tCi (= 0.4 M) and L-[2, 3, 4, 5-3H]arginine monohydrochloride
(62 Ci/mmol; Amersham International, Bucks, United Kingdom).
After a 30-mm incubation at 37#{176}C,the reaction was stopped by adding
2 ml of 20 mM Hepes-Na, pH 6.0, containing 2 mM ethylenediamine
tetra-acetic acid. The whole reaction mixture was applied to 2-ml
columns of Dowex AG5OWX-8 (Nat form; Aldrich, Milano, Italy)
and eluted with 4 ml of water. At pH 6.0, arginine is negatively
charged, whereas citrulbine is neutral; the Dowex resin is a cationic
exchanger that binds arginine but not citrulline in these conditions.
The radioactivity corresponding to [3H]citrulline content in the 6-mb
eluate was measured by liquid scintillation counting. NOS activity
was expressed as picomoles of citrulline generated per minute
of incubation per milligram of EC protein. The protein content of
EC was assessed with the modified micro-Lowry method (kit from
Sigma). T End.l cells have a detectable basal NOS activity (21).
However, NOS activity of EC incubated with various dialysis fluids
was expressed in our experiments as fold increase compared with
values obtained in cells incubated with DMEM.
RNA Extraction and Reverse Transcription-PCR
Amplification of mRNA for Inducible NOS
Total RNA was extracted from EC and snap-frozen in liquid
nitrogen, using the RNAzol (Cinna-Biotech, Houston, TX) method,
following the manufacturer’s instructions. EC were suspended in
RNAzo1 at the proportion of 106 cells/ml. The suspension was vor-
texed for 15 s and incubated in chloroform at 4#{176}Cfor 15 mm. After
12,000 x g centrifugation at 4#{176}Cfor 15 mm, the supernatant was
extracted with an equal volume of isopropanol. After another incuba-
tion at -20#{176}Cfor 45 mm and 12,000 X g centrifugation for 15 mm,
the pellet was washed twice in 75% ethanol and resuspended in
double-distilled water. The concentration and purity of RNA were
determined by absorbance at 260 and 280 nm.
Reverse transcription of total RNA to cDNA was performed using
the reverse transcription system (Promega, Madison, WI). Briefly, 2
,.tg of total RNA were transcribed to cDNA, adding 25 U of reverse
transcriptase, 1 j.tg of oligo dT. 5 p.1 of 10 mM dNTP mixture, 20 U
of RNAsin, and 10 pA of 25 mM MgCl2. The whole mixture was
incubated at 42#{176}Cfor 30 mm.
The eDNA specific for inducible NOS (iNOS) was amplified by
the PCR technique, using the Taq polymerase kit (Perkin-Elmer
Cetus, Norwalk, CT) with the following primers specific for iNOS
(up: 5’-CgTggAggCTgCCCggCAgACTgg-3’. down 5 ‘-TgCCCg-
gAAggTTTgTACAgCCCA -3’) (22). Five microliters of eDNA were
added to primers, MgCl2, dNTP, 1.2 U of Taq polymerase, and
amplification buffer. Thirty cycles of amplification were performed
( I mm at 60#{176}C,1 mm at 94#{176}C,2 mm at 60#{176}C,and 3 mm at 72#{176}C).The
cDNA was then run on a I % agarose gel, and bands were visualized
after ethidium bromide staining on an ultraviolet transilluminator. The
specificity of the bands was confirmed by Southern blot, using iNOS
cDNA. As a housekeeping control gene. we amplified mouse j3-actin
mRNA, using commercial primers (Clontech Laboratories, Palo Alto,
CA).
Cell Growth
[3H]thymidine incorporation assay was performed in 96-well mi-
crotiter plates in 200 j.d total volume. At the end of the 24-h incuba-
tion period with supplemented or unsupplemented media, cells were
pulsed overnight with [3H]thymidmne (I MCi/well, 5 to 7 Ci/mmol;
Amersham, Arlington Heights, IL). Cells were collected on glass
microfiber filters (934-AH, Whatman, Clifton, NJ), using a cell har-
vester, and radioactivity was assessed after placing the filters in liquid
scintillation fluid and counted in a a-counter.
TNF Measurement
TNF-ct was measured in supernatants of EC incubated for 6 h in
various conditions by a commercial competitive immunoassay (T Cell
Diagnostics, Inc., Cambridge, MA), according to the manufacturer’s
instructions. Our intra- and interassay coefficients of variation, eval-
uated in 10 different assays, were 7 ± 2 and 8 ± 3%, respectively.
The levels of TNF-a were corrected for the protein cellular content
and expressed as fold increases compared with values in unsupple-
mented media.
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Endotoxin Concentration
The concentration of endotoxin was determined in dialysate fluids
at 405 nm by using Limulus Amebocyte Lysate (LAL) as a chromo-
genic substrate. The LAL was supplied by MA. Bioproducts (Gaith-
ersburg, MD), and the substrate was supplied by Kabi (Stockholm,
Sweden); Escherichia co/i 0 III: B4 was used as a standard.
The activity of 1 ng was equivalent to 12.5 endotoxin units (EU) of
the U.S. reference standard EC-5. The sensitivity of the test was 0.01
ng/ml. Negative values were considered 0.5 EU/mI.
Statistical Analyses
Values reported in the results represent mean ± SD of five exper-
iments, each performed in triplicate. Paired t test and Mann-Whitney
nonparametric analysis were used to compare different conditions.
Results
NOS Activity in EC
Acetate at the standard concentration of the dialysis fluids
(38 mmollL) induced a 3.2 ± 0.39-fold increase of basal EC
NOS activity (0.028 ± 0.01 pmol NO/mm per mg protein)
(P < 0.0005) (Figure 1 ). Also, the small amount of acetate
present in bicarbonate buffer (4 mmol/L) stimulated the basal
EC NOS activity by a 2 ± 0.49-fold increase over basal values
(P < 0.005). AFB did not modulate the EC NOS basal activity.
As expected, LPS induced a 22 ± 2.4-fold increase of EC
NOS basal activity (P < 0.0001), and the addition of LPS to
each dialysis buffer examined blunted the effect of the dialysis
buffers on EC NOS activity.
mRNA Encoding for iNOS Expressed by Cultured EC
Standard qualitative reverse transcniption-PCR demon-
strated a high expression of iNOS mRNA in EC incubated with
acetate at the concentration of 38 mmollL and even in the small
amount present in the bicarbonate buffer (4 mmol/L), whereas
AFB produced no effect on basal iNOS mRNA expression
(Figure 2). As expected. LPS was a potent enhancer of EC
iNOS mRNA levels.
TNF Synthesis of EC Incubated with Different Dialysis
Buffers
Acetate induced a clear increase in TNF synthesis compared
with the basal values (5 ± 1 .44-fold increase when cells were
incubated with acetate, P < 0.0005; and 3 ± 0.7-fold with
bicarbonate, P < 0.005) (Figure 3). AFB did not modify the
basal EC TNF production. LPS was a powerful inducer of EC
TNF synthesis with a 20 ± 2.34-fold increase of basal values
(P < 0.0001).
EC Proliferative Index
Acetate at concentrations of both 38 and 4 mmollL induced
a significant reduction of the EC proliferative index (25 ± I 2
and 44 ± 3% of basal values; P < 0.0005 and P < 0.005,
respectively) (Figure 4). The EC proliferative index was not
influenced by the incubation with AFB.
Endotoxin Concentration
LAL was always negative in cell cultures incubated with the
different dialysis buffers.
Discussion
These data suggest a previously unconsidered mechanism
for acetate to induce vasodilation during dialysis. We demon-
strated that the coincubation of EC with acetate-buffered dial-
ysis fluid at a concentration of 38 mmolIL, as well as with the
small amounts present in bicarbonate buffer (4 mmollL), sig-
nificantly increased in vitro NOS activity. In contrast, the
coincubation with AFB failed to modify NOS activity.
Mammalian cells have at least three genes encoding for each
distinct isoform of NOS, which share 50 to 60% homology
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Figure 1. Nitric oxide synthase (NOS) activity of endothebial cells (EC) after incubation with different dialysis buffers. Results are expressed
as fold increase over basal values (mean ± SD of five experiments). P values refer to nonparametric Mann-Whitney U test. Basal, NOS activity
of EC in arbitrary units; Acet, acetate dialysis buffer (38 mmollL); Bic, bicarbonate dialysis buffer (bicarbonate 35 mmolfL, acetate 4 mmol/L);
AFB, acetate-free dialysis buffer; LPS, lipopolysaccharide (10 pg/ml). *P < 0.0005; ** < 0.05; *** < 0.005.
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Figure 3. TNF-a release after incubation with different dialysis buffers. Results are expressed as fold increase over basal values. Abbreviations
as in Figure 1 . *P < 0.0005; ** < 0.005; *** < 0.05.
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Figure 2. PCR amplification of specific mRNA encoding for inducible NOS (iNOS) and -actin in EC after incubation with different dialysis
buffers (representative of three separate experiments). Lane 1 , acetate; lane 2, bicarbonate; lane 3, AFB; lane 4, LPS.
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with one another at nucleotide and amino acid levels (23). Two
NOS gene products are constitutively expressed: one in EC
(eNOS) and a second in neuronal (nNOS) and other cell types,
including kidney macula densa cells, skeletal muscles, j3 pan-
creatic cells, and epithelial cells of the lung. The third species
of NOS is inducible by different stimuli in virtually all nude-
ated mammalian cells examined (iNOS). Although all NOS
isoforms require bound calmodulin for activity, only the iNOS
has a sufficiently high avidity for calmodulin to remain bound
at the low calcium levels found in resting cells, conferring the
full catalytic activity to iNOS (24). As a result, eNOS and
nNOS probably produce small, physiological “puffs” of NO in
response to transient elevation in intracellular calcium,
whereas iNOS produces a large and continuous flux of NO
until the substrate becomes limiting. On the basis of these
observations, calcium-independent iNOS, rather than calcium-
dependent constitutive eNOS and nNOS, is thought to be the
isoform producing the large quantities of NO leading to tissue
damage or death. Only in some pathologic conditions such as
stroke (25) or after ischemia/repenfusion (26), a sufficiently
continuous elevation in intracellular calcium may cause the
constitutive NOS isoforms to produce cytotoxic quantities of
NO.
Because the measurement of NOS enzymatic activity does
not distinguish constitutive NOS and iNOS, we focused our
attention on iNOS, which, for the above considerations, could
largely be involved in acetate intolerance. By using reverse
transcription-PCR, we demonstrated high levels of the specific
mRNA encoding for iNOS only in EC incubated with acetate
or bicarbonate buffer containing trace amounts of acetate.
Acetate increases production and release of IL- 1 /3. and this
effect is further enhanced when the cells are incubated with
endotoxin (1 1). It is well known that IL- 1 f3 secretion can be
induced by endotoxin or complement activation products (27)
and that, in turn, IL-13 promotes TNF-a release (28) and many
other immune system activities. These cytokines are thought to
play a central role in various dialysis intolerance reactions,
particularly in hemodialysis-associated hypotension (29,30).
Recent evidence has been provided that TNF-a does not in-
crease the constitutive NOS, but is a potent enhancer of the
inducible form of the enzyme in various cellular systems
(31,32).
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Figure 4. Proliferative index of EC grown after
different dialysis buffers. Results are expressed as
versus the basal values. Abbreviations as in Figure
**P < 0.005.
We demonstrated that acetate significantly increased endo-
thelial TNF, whereas AFB was ineffective. The negative LAL
test ensured the purity of the dialysis fluid used, thus excluding
NOS activation by LPS. It is conceivable that the increase in
iNOS mRNA levels and NOS enzymatic activity are a result of
the induction of TNF by acetate in synergism with cAMP.
Because NO is an antiproliferative mediator ( 1 3), we eval-
uated the effect of acetate on the proliferative index of EC.
Acetate buffer and bicarbonate buffer containing low amounts
of acetate significantly reduced EC proliferation activity,
whereas acetate-free solution failed to show any effect.
In conclusion, the data obtained support our hypothesis that
acetate produces its vasodilatory effects by means of NO. The
increase in cAMP and the stimulation of TNF-a transcription
and translation suggest the possibility of a combined activation
of constitutive NOS and iNOS.
Because the constitutive isoform of NOS functions in basal
conditions, the effect of its stimulation is immediate and leads
to rapid synthesis of NO. Therefore, the stimulation of consti-
tutive NOS by acetate suggests the possibility of involvement
of NO in intradialytic hypotension. Moreover, because we
found an increase in iNOS mRNA levels, which may be due
either to enhanced gene transcription or increased RNA stabil-
ity, we propose that patients undergoing acetate dialysis, and
even more when using poorly biocompatible membranes (33),
are exposed to periodic stimulation of endothelial iNOS. Its
final product, NO, could play a role in the development of
long-term chronic vasculopathy of dialyzed patients.
Even though the clinical relevance of these “in vitro” studies
has to be proved in vivo, it is worth noting that acetate, even in
low concentrations, in bicarbonate buffer can modulate iNOS
mRNA levels and enzymatic activity, whereas only dialysis
solutions free of acetate do not activate this powerful mediator.
The small amounts of acetate present in bicarbonate dialy-
sate, although capable of inducing in vitro NOS activation, are
likely to be rapidly metabolized so that acetatemia does not
stimulate NOS activity. Conversely, high acetate levels during
acetate dialysis overwhelm the hepatic metabolic capacity and
are likely to lead to increased NO production with related
clinical signs and symptoms.
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